Invention Grant
- Patent Title: Glucuronylation as a new acidic post-translational modification on therapeutic monoclonal antibodies
-
Application No.: US16260482Application Date: 2019-01-29
-
Publication No.: US11366123B2Publication Date: 2022-06-21
- Inventor: Shunhai Wang
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: McCarter & English, LLP
- Agent John P. Isacson
- Main IPC: G01N33/543
- IPC: G01N33/543 ; G01N33/68 ; C07K1/18 ; C07K16/00 ; C07K1/16 ; C07K1/22
Abstract:
Compositions and methods for identifying glucuronylated protein drug products are provided.
Public/Granted literature
- US20190234964A1 GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES Public/Granted day:2019-08-01
Information query
IPC分类:
